Literature DB >> 2650298

Synergistically enhanced immunosuppressive effect by combined use of cyclosporine and mizoribine.

H Amemiya1, S Suzuki, H Watanabe, R Hayashi, S Niiya.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2650298

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.

Authors:  A Zeevi; M Woan; G Z Yao; R Venkataramanan; S Todo; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 2.  Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols.

Authors:  R Indudhara; R B Khauli
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

3.  Inhibition of cyclin A gene expression in human B cells by an immunosuppressant mizoribine.

Authors:  S Hirohata; K Nakanishi; T Yanagida
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 4.  New immunosuppressive agents for pediatric transplantation.

Authors:  M Ferraresso; B D Kahan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

5.  Genetic and clinical determinants of mizoribine pharmacokinetics in renal transplant recipients.

Authors:  Rui Dai; Jingjie Li; Jingjing Wu; Qian Fu; Jiajia Yan; Guoping Zhong; Changxi Wang; Xiao Chen; Pan Chen
Journal:  Eur J Clin Pharmacol       Date:  2020-08-15       Impact factor: 2.953

6.  Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.

Authors:  L A Turka; J Dayton; G Sinclair; C B Thompson; B S Mitchell
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.